ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

Home-Based Program Helps Older Cancer Survivors

May 29, 2009

OMB Reprogramming Ban Criticized

September 20, 1985